Triple
T22693404
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | RNA polymerase II |
E561106
|
entity |
| Predicate | interactsWith |
P3970
|
FINISHED |
| Object | TFIID |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: TFIID | Statement: [RNA polymerase II, interactsWith, TFIID]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: TFIID Context triple: [RNA polymerase II, interactsWith, TFIID]
-
A.
CTCF
CTCF is a state prison facility in Colorado that houses incarcerated individuals under the jurisdiction of the Colorado Department of Corrections.
-
B.
RNA polymerase II
RNA polymerase II is the eukaryotic enzyme complex responsible for transcribing DNA into messenger RNA and many non-coding RNAs, playing a central role in gene expression.
-
C.
MAFA transcription factor
MAFA transcription factor is a beta cell–specific transcription factor that plays a key role in regulating insulin gene expression and pancreatic islet function.
-
D.
EFT-1
EFT-1 is NASA's first uncrewed test flight of the Orion spacecraft, conducted in 2014 to evaluate its critical systems during high Earth orbit and reentry.
-
E.
TARDBP
TARDBP is a gene encoding the TDP-43 protein, a DNA/RNA-binding protein whose abnormal aggregation is a key pathological feature in amyotrophic lateral sclerosis and related neurodegenerative diseases.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: TFIID Target entity description: TFIID is a multi-subunit transcription factor complex that recognizes core promoter elements and helps recruit RNA polymerase II to initiate gene transcription in eukaryotic cells.
-
A.
CTCF
CTCF is a state prison facility in Colorado that houses incarcerated individuals under the jurisdiction of the Colorado Department of Corrections.
-
B.
RNA polymerase II
RNA polymerase II is the eukaryotic enzyme complex responsible for transcribing DNA into messenger RNA and many non-coding RNAs, playing a central role in gene expression.
-
C.
MAFA transcription factor
MAFA transcription factor is a beta cell–specific transcription factor that plays a key role in regulating insulin gene expression and pancreatic islet function.
-
D.
EFT-1
EFT-1 is NASA's first uncrewed test flight of the Orion spacecraft, conducted in 2014 to evaluate its critical systems during high Earth orbit and reentry.
-
E.
TARDBP
TARDBP is a gene encoding the TDP-43 protein, a DNA/RNA-binding protein whose abnormal aggregation is a key pathological feature in amyotrophic lateral sclerosis and related neurodegenerative diseases.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e2454d71b48190a1f80af9f82b6fcf |
completed | April 17, 2026, 2:35 p.m. |
| NER | Named-entity recognition | batch_69f1789c6ae481908975b7d27e7624ac |
completed | April 29, 2026, 3:18 a.m. |
Created at: April 17, 2026, 3:13 p.m.